Financials
- Market Capitalization 37.45 B
- Employee 33 K
- Founded N/A
- CEO Richard Francis
- Website www.tevapharm.com
- Headquarter Israel
- FIGI BBG000C0CD58
- Industry Fabricantes de medicamentos — especializados y genéricos
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
22.48
Relación precio/flujo de caja
2.49
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 352 | HLN Haleon plc American Depositary Shares | 9.86 USD | +1.02% | -0.50% | +8.23% | +0.10% | 44.14 B USD | ||
| 435 | ZTS Zoetis Inc. Class A Common Stock | 75.39 USD | -0.19% | -1.53% | -8.45% | -48.48% | 31.61 B USD | ||
| 505 | TAK Takeda Pharmaceutical Company Limited American Depositary Share | 16.49 USD | -0.42% | -2.48% | +3.06% | +16.25% | 25.69 B USD | ||
| 613 | VTRS Viatris Inc. - Common Stock | 16.39 USD | +0.74% | -3.36% | -0.49% | +58.36% | 19.09 B USD |